Skip to main content
Clinical Trials/CTRI/2022/07/044415
CTRI/2022/07/044415Not yet recruiting未知

Fundus auto fluorescence and spectral domain optical coherence tomography in early detection of hydroxy chloroquine retinal toxicity

sankara Eye Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Patients who are taking hydroxychloroquine for atleast 2 years for,
  • Sjogrenâ??s syndrome,
  • Other connective tissue diseases

Exclusion Criteria

  • Anterior segment disease,
  • Retinal disease especially macular pathology
  • History of vitreoretinal surgery
  • Media opacity preventing fundus view

Investigators

Similar Trials

To detect early changes of hydroxy... | Clinical Trial